Key result
Percutaneous left atrial appendage closure serves as a non-inferior alternative to anticoagulation for stroke prevention in atrial fibrillation, despite a 1-3% residual tamponade rate and incomplete closure in one third of patients.
Answers are grounded in this paper and cite their sources.
LAAC is a viable alternative for stroke prevention in AF patients with contraindications to anticoagulation, though procedural complications and the need for comparison with DOACs remain.
KatetrizaÄnĂ uzĂĄvÄr ouĹĄka levĂŠ sĂnÄ (left atrial appendage closure, LAAC) pĹedstavuje alternativnĂ pĹĂstup v prevenci cĂŠvnĂch mozkovĂ˝ch pĹĂhod (CMP) u pacientĹŻ s fibrilacĂ sĂnĂ (FS). ĂdajĹŻ ve prospÄch tĂŠto formy "lokĂĄlnĂ" prevence tromboembolie u pacientĹŻ s vysoce rizikovĂ˝m skĂłre CHA2DS2-VASc stĂĄle pĹibĂ˝vĂĄ. UzĂĄvÄr ouĹĄka levĂŠ sĂnÄ by se mohl stĂĄt vĂ˝znamnou alternativou u pacientĹŻ s limitacemi/kontraindikacĂ k antikoagulaÄnĂ lĂŠÄbÄ. Ădaje ze dvou hlavnĂch randomizovanĂ˝ch klinickĂ˝ch studiĂ prokĂĄzaly uĹžiteÄnost a bezpeÄnost zaĹĂzenĂ WATCHMAN LAAC v prevenci CMP u pacientĹŻ s FS jako plnohodnotnĂŠ lĂŠÄebnĂŠ strategie. PĹes celkovou ĂşÄinnost vĹĄech dnes pouĹžĂvanĂ˝ch mechanickĂ˝ch okluderĹŻ (dokumentovanou prospektivnĂmi multicentrickĂ˝mi studiemi) mĹŻĹže jednoznaÄnĂ˝ pĹĂnos jejich pouĹžitĂ omezovat: (a) 1-3% incidence reziduĂĄlnĂ tamponĂĄdy; (b) nedosaĹženĂ ĂşplnĂŠho, tedy 100% uzavĹenĂ u tĹetiny pacientĹŻ; (c) embolizaÄnĂ komplikace vÄetnÄ embolizace okluderu. Pro zlepĹĄenĂ vĂ˝sledkĹŻ byly zkonstruovĂĄny novĂŠ generace tÄchto zaĹĂzenĂ s cĂlem dosĂĄhnout: (i) mĂŠnÄ traumatickĂŠho implantaÄnĂho vĂ˝konu; (ii) pĹesnÄjĹĄĂho umĂstÄnĂ a zakrytĂ ĂşstĂ ouĹĄka levĂŠ sĂnÄ (left atrial appendage, LAA). Tento ÄlĂĄnek shrnuje opodstatnÄnĂ vĂ˝konu, klinickĂŠ Ăşdaje, zaĹĂzenĂ, techniky implantace i lĂŠkovĂŠ reĹžimy v dalĹĄĂm sledovĂĄnĂ pacientĹŻ.ZĂĄvÄrem je tĹeba konstatovat, Ĺže potĹebujeme dalĹĄĂ Ăşdaje a studie k prokĂĄzĂĄnĂ principu LAAC, zvlĂĄĹĄtÄ v novĂŠ ĂŠĹe lĂŠÄby pĹĂmĂ˝mi perorĂĄlnĂmi antikoagulancii.
No takes yet. Share an insight, caveat, or question.
Neužil et al. (2016) conducted a review in Atrial fibrillation. Percutaneous left atrial appendage closure (LAAC) vs. Anticoagulation therapy (e.g., warfarin) was evaluated. Percutaneous left atrial appendage closure serves as a non-inferior alternative to anticoagulation for stroke prevention in atrial fibrillation, despite a 1-3% residual tamponade rate and incomplete closure in one third of patients.
Synapse has enriched 10 related papers. Consider them for comparative context: